Several clinical studies have reported that nearly a quarter of all women today are in perimenopause. Moreover, evidence suggests that about 20 percent of women’s will need effective treatment for hot flashes and night sweats to continue to be productive. Therefore, women are frequently prescribed with the antidepressants and anti-seizure drugs to reduce the symptoms of hot flashes.
However, there is a less evidence for the oral micronized progesterone (OMP) which reduces vasomotor symptoms (VMS) such as hot flashes and night sweats in perimenopausal women. Do OMP reduces the VMS in perimenopausal women? Source: Eurekalert
